Recent studies have shown that human bitter taste receptors (TAS2Rs) are not only expressed in mucous epithelial cells of the tongue, but also in epithelial cells of the colon, stomach and upper respiratory tract. These cell types come in close contact with external bitter compounds by ingestion or breathing. In the present work we addressed the question whether bitter taste receptors might also be expressed in cornified epithelial cells of the skin. Here, we show for the first time the expression of TAS2R1 and TAS2R38 in human skin. Double staining of HaCaT cells and primary keratinocytes demonstrated the colocalization of TAS2R1 and TAS2R38 with the adaptor protein α-gustducin that is essential for signal transduction upon ligand binding. To test if TAS2Rs in keratinocytes are functional, we stimulated HaCaT cells with diphenidol, a clinically used bitter-tasting antiemetic, or amarogentin, the bitterest plant substance, that binds TAS2Rs, including TAS2R1 and TAS2R38. Diphenidol and amarogentin induced calcium influx. Furthermore, in keratinocytes diphenidol and amarogentin stimulated the expression of the differentiation markers keratin 10, involucrin and transglutaminase. Therefore, apart from the known role in mucous membranes of the gastrointestinal tract, TAS2Rs are expressed in the epidermis and might play a role in keratinocyte differentiation.

Keywords:
Bitter taste receptors, Calcium influx, Human primary keratinocytes
1.
Callaway E: Evolutionary biology: the lost appetites. Nature 2012;486:S16-S17.
2.
Amrein H, Bray S: Bitter-sweet solution in taste transduction. Cell 2003;112:283-284.
3.
Rozengurt E, Sternini C: Taste receptor signaling in the mammalian gut. Curr Opin Pharmacol 2007;7:557-562.
4.
Deshpande DA, Wang WC, McIlmoyle EL, et al: Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010;16:1299-1304.
5.
Lindemann B: Receptors and transduction in taste. Nature 2001;413:219-225.
6.
Shah AS, Ben-Shahar Y, Moninger TO, Kline JN, Welsh MJ: Motile cilia of human airway epithelia are chemosensory. Science 2009;325:1131-1134.
7.
Behrens M, Born S, Redel U, et al: Immunohistochemical detection of TAS2R38 protein in human taste cells. PLoS One 2012;7:e40304.
8.
Meyerhof W, Batram C, Kuhn C, et al: The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses 2010;35:157-170.
9.
Rheinwald JG, Green H: Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975;6:331-343.
10.
Wolfle U, Esser PR, Simon-Haarhaus B, Martin SF, Lademann J, Schempp CM: UVB-induced DNA damage, generation of reactive oxygen species, and inflammation are effectively attenuated by the flavonoid luteolin in vitro and in vivo. Free Radic Biol Med 2011;50:1081-1093.
11.
Muller M, Essin K, Hill K, et al: Specific TRPC6 channel activation, a novel approach to stimulate keratinocyte differentiation. J Biol Chem 2008;283:33942-33954.
12.
Adler E, Hoon MA, Mueller KL, Chandrashekar J, Ryba NJ, Zuker CS: A novel family of mammalian taste receptors. Cell 2000;100:693-702.
13.
Kuhn C, Bufe B, Batram C, Meyerhof W: Oligomerization of TAS2R bitter taste receptors. Chem Senses 2010;35:395-406.
14.
Leung YM, Wong KL, Cheng KS, et al: Inhibition of voltage-gated K+ channels and Ca2+ channels by diphenidol. Pharmacol Rep 2012;64:739-744.
15.
Clark AA, Liggett SB, Munger SD: Extraoral bitter taste receptors as mediators of off-target drug effects. FASEB J 2012;26:4827-4831.
16.
Leuner K, Kraus M, Woelfle U, et al: Reduced TRPC channel expression in psoriatic keratinocytes is associated with impaired differentiation and enhanced proliferation. PLoS One 2011;6:e14716.
17.
Grether-Beck S, Felsner I, Brenden H, et al: Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 2012;132:1561-1572.
18.
Finger TE, Kinnamon SC: Taste isn't just for taste buds anymore. F1000 Biol Rep 2011;3:20.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.